iShares Biotechnology ETF (IBB) Holdings $128.00 -1.00 (-0.78%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$127.50 -0.50 (-0.39%) As of 06/13/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock Top 100 IBB HoldingsRankCompanyCurrent PriceWeightShares Held1GILDGilead Sciences$109.98-1.8%8.45%4,001,8672AMGNAmgen$295.22-0.7%8.26%1,484,9543VRTXVertex Pharmaceuticals$455.45-1.0%8.24%953,4194REGNRegeneron Pharmaceuticals$529.24+1.4%5.89%627,3135ALNYAlnylam Pharmaceuticals$307.99+1.1%4.36%736,7356IQVIQVIA$156.65-1.6%2.97%1,037,5907ARGXargenx$577.89-1.5%2.79%250,7598MTDMettler-Toledo International$1,153.65-2.9%2.78%122,5159NTRANatera$165.34+0.6%2.46%760,22910WATWaters$341.88-2.2%2.41%352,703 Get the Latest News and Ratings for IBB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11BIIBBiogen$130.65-1.3%2.21%866,59512BNTXBioNTech$106.57+1.6%2.09%971,16013UTHRUnited Therapeutics$283.35-1.0%1.65%262,21514ONCBeigene$269.63-2.5%1.64%327,07715ILMNIllumina$86.93-1.4%1.51%938,03216INSMInsmed$98.73+1.9%1.50%1,051,98617INCYIncyte$67.75-2.1%1.48%1,134,87518NBIXNeurocrine Biosciences$124.39-0.5%1.39%576,25319EXELExelixis$41.59-0.5%1.33%1,621,18620BMRNBioMarin Pharmaceutical$56.22-1.9%1.22%1,120,79421GMABGenmab A/S$22.82-1.2%1.16%2,746,79722MRNAModerna$26.67-2.5%1.07%2,033,79323BPMCBlueprint Medicines$127.96-0.2%0.93%373,34424TECHBio-Techne$50.52-2.0%0.90%930,28325MEDPMedpace$298.25-1.9%0.90%148,73526ASNDAscendis Pharma A/S$170.80-0.1%0.84%250,05827CRLCharles River Laboratories International$149.50-1.6%0.84%300,99428RGENRepligen$127.52-2.9%0.77%314,66429HALOHalozyme Therapeutics$53.98-1.0%0.76%724,75330RVMDRevolution Medicines$40.59-1.3%0.75%961,52831BBIOBridgeBio Pharma$39.78+0.3%0.65%888,75632IONSIonis Pharmaceuticals$35.59-0.1%0.63%920,74033MDGLMadrigal Pharmaceuticals$295.57-0.6%0.60%110,78834ALKSAlkermes$29.83-3.1%0.58%943,50135ROIVRoivant Sciences$11.32-1.3%0.57%2,632,20536TEMTempus AI$71.220.0%0.56%463,70737ADMAADMA Biologics$20.81-3.7%0.53%1,355,48538AXSMAxsome Therapeutics$104.10-2.0%0.50%238,42339PCVXVaxcyte$34.56+0.3%0.49%744,55040VRNAVerona Pharma$92.20-0.3%0.49%302,412[Wanted] 250 intrepid souls (Ad)He Called this 106X Opportunity Before Reddit… and Before Elon Musk Before GameStop rocketed up to 10,633, Jonathan Rose saw something strange: A sudden surge in options volume — thousands of contracts flooding in. The money hit deep inside the CBOE before Reddit posts created the short squeeze and before Elon's tweet sent GameStop flying. Jonathan calls it the "Big-Money Tell," and it's flagged dozens of big trade opportunities including: 462.5% in C3.ai, 245.13% in Criteo, and 39.46% in Roku. And these are just some of the gains the "tell" has identified. Even better: He says the next big set-up could be forming right now. And there's still time for you to get in before it kicks off as soon as seven days from now.Click here for the details from Jonathan himself.41BRKRBruker$38.30-3.9%0.45%613,37942PTCTPTC Therapeutics$51.26+0.5%0.45%457,74943RNAAvidity Biosciences$31.37-2.4%0.44%660,34244LEGNLegend Biotech$36.83-2.8%0.44%755,00145CYTKCytokinetics$34.38+3.6%0.43%685,86346RYTMRhythm Pharmaceuticals$62.90-0.2%0.42%334,24247ACADACADIA Pharmaceuticals$21.71-0.1%0.41%983,84548AKROAkero Therapeutics$55.62+3.8%0.41%396,00049MRUSMerus$54.61-1.4%0.41%364,23250SRPTSarepta Therapeutics$36.18-3.0%0.41%535,02451NUVLNuvalent$78.24+0.4%0.39%263,59952SWTXSpringWorks Therapeutics$46.78+0.0%0.38%417,29153KRYSKrystal Biotech$137.07-2.3%0.37%146,30154CRSPCRISPR Therapeutics$41.36+0.2%0.36%489,48355RAREUltragenyx Pharmaceutical$37.49-4.6%0.36%514,13656PTGXProtagonist Therapeutics$56.37+0.1%0.34%343,62057CRNXCrinetics Pharmaceuticals$31.77-1.2%0.32%515,12058ZLABZai Lab$41.00-4.7%0.31%450,09759ACLXArcellx$66.00-0.8%0.30%239,65060KYMRKymera Therapeutics$46.96-0.7%0.28%321,34561SRRKScholar Rock$32.45-2.6%0.26%433,92962SMMTSummit Therapeutics$19.78-1.9%0.26%683,28563XENEXenon Pharmaceuticals$32.76-0.1%0.26%441,13264BCRXBioCryst Pharmaceuticals$10.37-0.3%0.25%1,171,93865VCELVericel$42.67+0.4%0.25%293,90166VCYTVeracyte$26.44-0.9%0.24%455,17067AGIOAgios Pharmaceuticals$34.30-0.6%0.22%328,22068APLSApellis Pharmaceuticals$18.83-2.2%0.22%615,57369FOLDAmicus Therapeutics$6.03-2.3%0.21%1,763,08770DNLIDenali Therapeutics$14.55-2.5%0.21%747,36271ARWRArrowhead Pharmaceuticals$15.74-3.0%0.20%623,93172IDYAIDEAYA Biosciences$22.18-0.4%0.20%480,08073MIRMMirum Pharmaceuticals$49.63+1.2%0.20%231,42274TWSTTwist Bioscience$33.52-0.3%0.20%335,06175GRFSGrifols$8.87-1.2%0.19%1,130,13976NVCRNovoCure$17.55-3.6%0.19%587,61677VERAVera Therapeutics$22.74+1.0%0.18%288,88178BEAMBeam Therapeutics$17.06-2.2%0.17%523,41179RXRXRecursion Pharmaceuticals$4.92-4.8%0.17%1,765,72680ETNB89bio$10.41+8.2%0.16%824,83181ADPTAdaptive Biotechnologies$10.32-0.9%0.16%848,53482ARQTArcutis Biotherapeutics$13.43-0.5%0.16%620,84983BHVNBiohaven$15.43-1.1%0.16%525,25884TARSTarsus Pharmaceuticals$40.89-0.1%0.16%196,75485APGEApogee Therapeutics$44.48+6.3%0.15%214,82986MNKDMannKind$3.71-3.1%0.15%1,752,38787TVTXTravere Therapeutics$14.50-2.9%0.15%519,45388ALVOAlvotech$9.74-1.0%0.14%648,84889CGONCG Oncology$25.86-2.4%0.14%274,25490DVAXDynavax Technologies$10.27-1.3%0.14%704,946Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. Click here to see the Tesla shock that could blindside everyone.91JANXJanux Therapeutics$24.90-2.6%0.14%285,89292DYNDyne Therapeutics$14.41-0.3%0.13%499,56093GRALGrail$41.31-1.5%0.13%166,72394IMCRImmunocore$34.68-2.7%0.13%183,22395NAMSNewAmsterdam Pharma$20.21-3.9%0.13%336,85196STVNStevanato Group€23.40-2.5%0.13%294,12197IRONDisc Medicine$53.71+1.9%0.12%126,15198EWTXEdgewise Therapeutics$15.29-0.8%0.12%440,20199IMVTImmunovant$15.66-1.8%0.12%412,293100MESOMesoblast$11.78-3.1%0.12%526,673 Geographic ExposureUnited States96.3%Netherlands0.6%Ireland0.6%Bermuda0.6%Canada0.5%Switzerland0.4%Jersey0.2%Virgin Islands, British0.2%Italy0.1%Luxembourg0.1%Singapore0.1%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care99.1%Consumer Discretionary0.3%Biotechnology0.1%Industrials0.1%Energy0.1%Life Sciences Tools & Services0.1%Industry ExposureBiotechnology80.3%Health Care Equipment & Supplies9.0%Health Care Providers & Services6.4%Pharmaceuticals1.6%Life Sciences Tools & Services1.1%Diversified Consumer Services0.9%Distributors0.2%Commercial Services & Supplies0.1%Renewable Energy0.1%Chemicals0.1%SubIndustry ExposureBiotechnology76.4%Life Sciences Tools & Services10.7%Health Care Services6.4%Pharmaceuticals2.5%Health Care Equipment0.4%Renewable Energy Equipment0.1%Coupon Exposure0-299.8%4-60.2% Related Companies and Tools Related Companies PPH Holdings BBH Holdings PSCH Holdings PTH Holdings LFSC Holdings BIB Holdings HEAL Holdings IBBQ Holdings FTXH Holdings MEDX Holdings This page (NASDAQ:IBB) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
